PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer - Aix-Marseille Université Access content directly
Journal Articles European Journal of Cancer Year : 2017

PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer

Anthony Gonçalves

Domains

Cancer
No file

Dates and versions

hal-03623711 , version 1 (29-03-2022)

Identifiers

Cite

Mathilde Guerin, Keyvan Rezai, Nicolas Isambert, Mario Campone, Aurélie Autret, et al.. PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer. European Journal of Cancer, 2017, 86, pp.28-36. ⟨10.1016/j.ejca.2017.08.025⟩. ⟨hal-03623711⟩
17 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More